HLS THERAPEUTICS INC (HLS.CA) Stock Balance Sheet
TSX:HLS - Toronto Stock Exchange - CA40390B1094 - Common Stock - Currency: CAD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 17.73M | 17.46M | 21.95M | N/A | N/A | |||
| Cash Equivalents | N/A | N/A | N/A | 20.70M | 21.20M | |||
| Receivables | 7.80M | 7.53M | 10.69M | 11.20M | 11.50M | |||
| Inventories | 7.48M | 9.06M | 9.53M | 8.90M | 8.90M | |||
| Other Current Assets | 1.05M | 1.36M | 1.92M | 3.50M | 2.10M | |||
| Total Current Assets | 34.07M | 35.40M | 44.09M | 44.40M | 43.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 972.00K | 997.00K | 965.00K | 1.10M | 1.60M | |||
| Intangibles | 117.18M | 122.12M | 162.34M | 195.00M | 229.20M | |||
| Other Non-Current Assets | 1.73M | 1.39M | 1.66M | 1.10M | 1.40M | |||
| Total Non-Current Assets | 119.88M | 124.50M | 164.97M | 197.30M | 232.10M | |||
| TOTAL ASSETS | 153.95M | 159.90M | 209.06M | 241.70M | 275.90M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 5.69M | 5.28M | 5.16M | 13.60M | 12.60M | |||
| Accounts Payable | 8.68M | 8.71M | 14.11M | 11.60M | 9.30M | |||
| Other Current Liabilities | 9.47M | 8.55M | 7.42M | 6.00M | 5.80M | |||
| Total Current Liabilities | 23.84M | 22.55M | 26.69M | 31.20M | 27.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 58.05M | 61.17M | 82.47M | 83.80M | 85.00M | |||
| Deferred Taxes/Income | 4.13M | 4.07M | 442.00K | 600.00K | 700.00K | |||
| Other Non-Current Liabilities | 1.13M | 778.00K | 1.77M | 800.00K | 1.90M | |||
| Total Non-Current Liabilities | 63.31M | 66.02M | 84.67M | 85.10M | 87.50M | |||
| TOTAL LIABILITIES | 87.15M | 88.56M | 111.36M | 116.30M | 115.20M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -198.33M | -194.18M | -175.46M | -148.40M | -119.90M | |||
| Additional Paid In Capital | 14.89M | 15.14M | 13.87M | 13.80M | 11.70M | |||
| Common Shares | 260.14M | 260.60M | 262.13M | 265.20M | 265.90M | |||
| Other Shareholders' Equity | -9.90M | -10.21M | -2.84M | -5.30M | 3.00M | |||
| Shares Outstanding | 31.74M | 31.79M | 31.98M | 32.40M | 32.50M | |||
| Tangible Book Value per Share | -1.59 | -1.60 | -2.02 | -2.15 | -2.11 | |||
| Total Shareholders' Equity | 66.80M | 71.34M | 97.70M | 125.30M | 160.70M | |||
| TOTAL LIABILITIES AND EQUITY | 153.95M | 159.90M | 209.06M | 241.70M | 275.90M | |||
| Statistics | ||||||||
| Debt/Equity | 0.87 | 0.86 | 0.84 | 0.67 | 0.53 | |||
| Current Ratio | 1.43 | 1.57 | 1.65 | 1.42 | 1.58 | |||
| Return On Assets (ROA) | -11.68% | -12.29% | -13.17% | -9.76% | -4.75% | |||
| Return On Equity (ROE) | -26.92% | -27.55% | -28.18% | -18.83% | -8.15% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | N/A | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.28